// startup autopsy
Pluromed
A decade of polymer innovation that found its exit through acquisition, not IPO.
marketfitAcqui-hire
Fatal mistake: Raised insufficient capital to independently commercialize a capital-intensive medical device technology, making acquisition the only viable exit.
Key Events Timeline
FOUNDING
Pluromed founded in the USA to develop thermoreversible polymer technology for vascular surgery applications.
PRODUCT LAUNCH
LeGoo, the flagship thermoreversible vascular occluder, enters clinical development and early surgical trials.
FUNDING
Secured funding rounds totaling $2.44M over the company's life to advance regulatory approval and clinical validation.
ACQUISITION ATTEMPT
Strategic acquirer approaches Pluromed to license and commercialize LeGoo technology, initiating acquisition negotiations.
SHUTDOWN
Pluromed is acquired, ending its independent operations after nearly a decade of biotech development.